apteka.lviDrugs24.com

Monthly offers  -Prices-Offer price Monthly offers 
Latvian pharmacies maps Duty doctors. medicaid
Medicines and generics searching-PricesDrugs search by alphabet
Vaccination offers. Pricelists-Prices-Offer price Vaccination offers
Space Weather Space weather
    
Queues for medical examinationsLists of compensated medicines        E‑health         
 LV 

ZYRTEC TBL 10MG N10 N30

Attention: Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for treating a health problem or disease, or prescribing any medication. iDrugs24.com is not responsible for any damage to your health as the result of self treatment.

# On 2024-Apr-26
ZYRTEC-N10-drug/medicine -tablets aproximate price on "ZYRTEC TBL 10MG N10 N30" in Riga city, Latvia is:
  • 5.80€  6.22$  4.97£  670Rub  67.5SEK  25PLN  23.57₪ 

ZYRTEC, 10 mg, plėvele dengtos tabletės, N10


Maximum allowed state defined price ( from ZVA webpage) Euro:State defined maximum allowed price indicated on the picture on drug/medicine -tablets  ZYRTEC TBL 10MG N10 N30     Recheck

Reģ. Nr.: I000201

ATC codeR06AE07 

Active substances: Cetirizini Dihydrochloridum

 


Vendor, principal: Ucb Pharma Oy
No prescription needed/Patient care products, dressings, gloves, medical devices,...

Similar or the same name medicines, products list *
Medicament / Item title  Prices Pharmacies chain
ZYRTEC 10 MG PLĖVELE DENGTOS TABLETĖS N10 (UCB Pharma SA)
3.93€, Apr.2024 Internet pharmacy Lithuania 100 metų vaistinė (Lithuania) Phone: +37038159292Buy
ZYRTEC 10MG PLĖVELE DENGTOS TABLETĖS N10
4.17€, Apr.2024 Internet pharmacy Lithuania Camelia vaistine, evaistine.camelia.lt (Lithuania) Phone: 880077000Buy
ZYRTEC 10 MG PLĖVELE DENGTOS TABLETĖS N10
4.27€, Apr.2024 Internet pharmacy Lithuania Gintarinė vaistinė nvaistine.lt (Lithuania) Phone: 880010008Buy
ZYRTEC 10 MG PLĖVELE DENGTOS TABLETĖS (L.IMP) N10
4.27€, Apr.2024 Internet pharmacy Lithuania Gintarinė vaistinė nvaistine.lt (Lithuania) Phone: 880010008Buy
ZYRTEC 10MG PLĖVELE DENGTOS TABLETĖS N10
4.35€, Apr.2024 Internet pharmacy Lithuania Camelia vaistine, evaistine.camelia.lt (Lithuania) Phone: 880077000Buy
ZYRTEC 10 MG PLĖVELE DENGTOS TABLETĖS N10
4.41€, Apr.2024 Internet pharmacy Lithuania Benu vaistinė (Lithuania) Phone: +37037401099Buy
ZYRTEC TBL 10MG N10 (TML)
4.59€, Apr.2024 Pharmacy Estonia Valga südameapteek (Estonia) Phone: +3727668005Buy
ZYRTEC ÕHUK. POLÜM.KAT. TBL 10MG N10, (TML), tsetirisiin
4.59€, Apr.2024 Pharmacy Estonia Aptev.ee, OÜ Mai apteek (Estonia) Phone: 6008844Buy
ZYRTEC TBL 10MG N10 (TML)
4.59€, Apr.2024 Pharmacy Estonia Valga selveri apteek. Apotheka.ee (Estonia) Phone: +3727661766 Buy
ZYRTEC ÕHUK. POLÜM.KAT. TBL 10MG N10, tsetirisiin
4.66€, Apr.2024 Pharmacy Estonia Aptev.ee, OÜ Mai apteek (Estonia) Phone: 6008844Buy
ZYRTEC ÕHUKE POLÜMEERKATTEGA TBL 10MG N10
4.66€, Apr.2024 Pharmacy Estonia Benu Veebiapteek (Estonia) Phone: +3726119070Buy
ZYRTEC TBL 10MG N10
4.66€, Apr.2024 Pharmacy Estonia Benu Apteek (Estonia) Phone: +3726119070
ZYRTEC 10MG TAB. N10
4.72€, Apr.2024 Internet pharmacy Lithuania www.apotheka.lt (Lithuania) Phone: +37066659028Buy
ZYRTEC 10 MG TABLETĖS, N10
5.25€, Apr.2024 Internet pharmacy Lithuania Mano vaistine LT (Lithuania) Phone: +37038233014Buy
ZYRTEC 10 MG PLĖVELE DENGTOS TABLETĖS N10
5.25€, Apr.2024 Internet pharmacy Lithuania Benu vaistinė (Lithuania) Phone: +37037401099Buy
ZYRTEC 10MG TABLETES N10
5.51€ , Apr.2024 Internet pharmacy Latvija Maija Aptieka, Skrunda, Alsunga Phone: +37163350065Buy
ZYRTEC 10 MG APVALKOTĀS TABLETES, N10 (Ucb Pharma Oy)
5.78€, Apr.2024 Internet pharmacy Latvija Saules aptieka Phone: +37125672567Buy
* This table was compiled fully automatically, independently from any advertisers, transparently and without any modification relaying the open offers available on the mentioned dates.
ZYRTEC 10 mg plėvele dengtos tabletės N10

 .

ZYRTEC 10MG N10

Package leaflet: Information for the user

Zyrtec 10 mg film-coated tablets

Cetirizine dihydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Always take this medicine exactly as described in this leaflet, or as your doctor or pharmacist have told you.
-   Keep this leaflet. You may need to read it again.
-   Ask your pharmacist if you need more information or advice.
-   If you get any side effects, talk to your doctor or pharmacist.This includes side effects not listed in this leaflet. See section 4.
-   You must talk to a doctor if you do not feel better or if you feel worse after 3 days.

What is in this leaflet:

1.   What Zyrtec is and what it is used for
2.   What you need to know before you take Zyrtec
3.   How to take Zyrtec
4.   Possible side effects
5.   How to store Zyrtec
6.   Content of the pack and further information

1. What Zyrtec is and what it is used for

Cetirizine dihydrochloride is the active ingredient of Zyrtec.
Zyrtec is an antiallergic medication.
In adults and children aged 6 years and above, Zyrtec 10 mg film-coated tablets are indicated
-   for the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis.
-   for the relief of urticaria.

2. What you need to know before you take Zyrtec Do not take Zyrtec

-   if you have a severe kidney disease (severe renal failure with creatinine clearance below 10 ml/min);
-   if you are allergic to cetirizine dihydrochloride, to any of the other ingredients (listed in section 6), to hydroxyzine or to piperazine derivatives (closely related active ingredients of other medicines).

Warning and precautions

Ask your doctor or pharmacist for advice before taking Zyrtec.
If you are a patient with renal insufficiency, please ask your doctor for advice; if necessary, you will take a lower dose. The new dose will be determined by your doctor.
If you have problems passing urine (like spinal cord problems or prostate or bladder problems), please ask your doctor for advice.
If you are an epileptic patient or a patient at risk of convulsions, you should ask your doctor for advice.
No clinically significant interactions have been observed between alcohol (at the blood level of 0.5 per mille (g/l) corresponding to one glass of wine) and cetirizine used at the recommended doses. However, there are no data available on the safety when higher doses of cetirizine and alcohol are taken together. Therefore, as it is the case with all antihistamines, it is recommended to avoid taking Zyrtec with alcohol.
If you are scheduled for allergy testing, ask your doctor if you should stop taking Zyrtec for several days before testing. This medicine may affect your allergy test results.

Children

Do not give this medicine to children below the age of 6 years because the tablet formulation does not allow the necessary dose adjustments.

Other medicines and Zyrtec

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Zyrtec with food and drink

Food does not affect absorption of Zyrtec.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Zyrtec should be avoided in pregnant women. Accidental use of the drug by a pregnant woman should not produce any harmful effects on the foetus. Nevertheless, the medicine should only be administered if necessary and after medical advice.
Cetirizine passes into breast milk. Therefore, you should not take Zyrtec during breast-feeding unless you have contacted a doctor.

Driving and using machines

Clinical studies have produced no evidence of impaired attention, alertness and driving capabilities after taking Zyrtec at the recommended dose.
You should closely observe your response to the drug after you have taken Zyrtec if you are intending to drive, engage in potentially hazardous activities or operate machinery. You should not exceed the recommended dose.
Zyrtec film-coated tablets contains lactose; if you have been told by your doctor that you have an intolerance to some sugars, please contact your doctor before taking this medicinal product.

3. How to take Zyrtec

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The tablets need to be swallowed with a glass of liquid.
The tablet can be divided into 2 equal doses.

Adults and adolescents above 12 years old:

The recommended dose is 10 mg once daily as 1 tablet.

Use in children between 6 and 12 years old:

The recommended dose is 5 mg twice daily as a half tablet twice daily.

Patients with renal impairment

Patients with moderate renal impairment are recommended to take 5 mg once daily.
If you suffer from severe kidney disease, please contact your doctor or pharmacist who may adjust the dose accordingly.
If your child suffers from kidney disease, please contact your doctor or pharmacist who may adjust the dose according to your child’s needs.
If you feel that the effect of Zyrtec is too weak or too strong, please consult your doctor.

Duration of treatment

The duration of treatment depends on the type, duration and course of your complaints. Please ask your doctor or pharmacist for advice.

If you take more Zyrtec than you should

If you think you have taken an overdose of Zyrtec please inform your doctor.
Your doctor will then decide what measures, if any, should be taken.
After an overdose, the side effects described below may occur with increased intensity. Adverse effects such as confusion, diarrhoea, dizziness, tiredness, headache, ailing, dilating of pupil, itching, restlessness, sedation, somnolence, stupor, abnormal rapid heart rate, tremors and urinary retention have been reported.

If you forget to take Zyrtec

Do not take a double dose to make up for a forgotten dose.

If you stop taking Zyrtec

Rarely, pruritus (intense itching) and/or urticaria may return if you stop taking Zyrtec.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4.   Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects are rare or very rare, but you must stop taking the medicine and speak to your doctor straight away if you notice them:

-   Allergic reactions, including severe reactions and angioedema (serious allergic reaction which causes swelling of the face or throat).
These reactions may start soon after you first take the medicine, or it might start later.
Common side effects (may affect up to 1 in 10 patients)
-   Somnolence (sleepiness)
-   Dizziness, headache
-   Pharyngitis, rhinitis (in children)
-   Diarrhea, nausea, dry mouth
-   Fatigue
Uncommon side effects (may affect up to 1 in 100 patients)
-   Agitation
-   Paresthesia (abnormal feelings of the skin)
-   Abdominal pain
-   Pruritus (itchy skin), rash
-   Asthenia (extreme fatigue), malaise
Rare side effects (may affect up to 1 in 1,000 patients)
-   Allergic reactions, some severe (very rare)
-   Depression, hallucination, aggression, confusion, insomnia
-   Convulsions
-   Tachycardia (heart beating too fast)
-   Liver function abnormal
-   Urticaria (hives)
-   Oedema (swelling)
-   Weight increased
Very rare side effects (may affect up to 1 in 10,000 patients)
-   Thrombocytopenia (low levels of blood    platelets)
-   Tics (habit spasm)
-   Syncope, dyskinesia (involuntary movements),    dystonia (abnormal prolonged muscular
contractions), tremor, dysgeusia (altered taste)
-   Blurred vision, accommodation disorder (difficulty focusing), oculogyration (eyes having uncontrolled circular movements)
-   Angioedema (serious allergic reaction which causes swelling of the face or throat), fixed drug eruption
-   Abnormal elimination of urine (bed wetting, pain and/or difficulty passing water)
Not known frequency of side effects (frequency cannot be estimated from the available data)
-   Increased appetite
-   Suicidal ideation (recurring thoughts of or preoccupation with suicide), nightmares
-   Amnesia, memory impairment
-   Vertigo (sensation of rotation or movement)
-   Urinary retention (inability to completely empty the urinary bladder)
-   Pruritus (intense itching) and/or urticaria upon discontinuation
-   Joint pain
-   Pustular rash
-   Hepatitis (inflammation of the liver).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via www.ravimiamet.ee . By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Zyrtec

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the box and blister. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.

6. Contents of the pack and other information

What Zyrtec contains

-   The active substance is cetirizine dihydrochloride. One film-coated tablet contains 10 mg cetirizine dihydrochloride.
-   The other ingredients are microcrystalline cellulose, lactose-monohydrate, colloidal anhydrous silica, magnesium stearate, Opadry Y-1-7000 (hydroxypropylmethylcellulose (E 464), titanium dioxide (E 171), macrogol 400).

What Zyrtec looks like and contents of the pack

White, oblong, film-coated tablet, with breakline and Y-Y logo.
Pack with 1, 4, 5, 7, and 10 tablets.
Not all pack sizes may be marketed

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:
UCB Pharma Oy Finland Bertel Jungin aukio 5 02600 Espoo Finland
Manufacturers:
Aesica Pharmaceuticals S.r.l., Via Praglia 15, I-10044 Pianezza (TO), Italy UCB Pharma Limited, 208 Bath Road, Slough, Berkshire, SL1 3WE, United Kingdom Phoenix Pharma Polska Sp. z o.o., ul. Oplotek 26, 01-940 Warsaw, Poland ExtractumPharma Co. Ltd., 6413 Kunfeherto, IV. körzet 6., Hungary
Movianto Polska Sp. z o.o, ul. Artura i Franciszka Radziwillow 5, 05-850 Ozarow Mazowiecki, Poland

This medicinal product is authorised in the Member States of the EEA under the following names:

Austria: Zyrtec 1 mg/ml - orale Lösung
Belgium: Zyrtec
Cyprus: Zyrtec
Denmark: Zyrtec
Estonia: Zyrtec
Finland: Zyrtec
France: Zyrtec
Ireland: Zirtek oral solution 1 mg/ml
Italy: Zirtec 1 mg/ml soluzione orale
Latvia: Zyrtec
Lithuania: Zyrtec
Luxemburg: Zyrtec
Malta: Zyrtec
Netherlands: Zyrtec
Noray: Zyrtec
Poland: Zyrtec
Portugal: Zyrtec
Slovenia: Zyrtec 1 mg/ml peroralna raztopina Spain: Zyrtec 1 mg/ml solucion oral Sweden: Zyrlex
United Kingdom: Zirtek allergy solution
This leaflet was last revised in June 2018.
6





  Instruction, annotation source for medicine: State Agency of Medicines, Estonia




European Medicines Agency Evaluation of Medicines for Human Use

London, 6 October 2008 Doc. Ref. EMEA/CHMP/541853/2008

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE

(CHMP)

OPINION FOLLOWING AN ARTICLE 30 REFERRAL FOR Zyrtec and associated names

International Non-Proprietary Name (INN): cetirizine

BACKGROUND INFORMATION

Zyrtec and associated names, 10 mg film coated tablets, 10 mg/ml oral drops, 1 mg/ml oral solution, is an anti-allergic drug indicated for the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis and for the relief of chronic idiopathic urticaria.

On 9 October 2007 the Commission presented to the EMEA a referral under Article 30 of Directive 2001/83/EC, as amended, in order to harmonise the nationally authorised Summaries of Product Characteristics (SPC), Labelling and Package Leaflet of the medicinal product Zyrtec and associated names.

The basis for referral was that there were divergences in the Summaries of Product Characteristics (SPC) of Zyrtec and associated names approved across EU Member States, in particular with respect to the indications, the posology, the contra-indications and the special warnings.

This medicinal product belongs to the 2007 list of products identified for SPC harmonisation.

The procedure started on 18 October 2007. The Marketing Authorisation Holder provided supplementary information on 28 January 2008.

During its May 2008 meeting, the CHMP, in the light of the overall submitted data and the scientific discussion within the Committee, was of the opinion that the proposal for the harmonisation of the SPC, Labelling and Package Leaflet was acceptable and that they should be amended.

The CHMP gave a positive opinion on 30 May 2008 recommending the harmonisation of the SPC, Labelling and Package Leaflet for Zyrtec and associated names.

The list of product names concerned is given in Annex I. The scientific conclusions are provided in Annex II together with the amended SPC, Labelling and Package Leaflet in Annex III.

A Decision was issued by the European Commission on 6 October 2008.

7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 86 13 E-mail: [email protected] http://www.emea.europa.eu © European Medicines Agency, 2008. Reproduction is authorised provided the source is acknowledged.



 Instruction , annotation source: The European Medicines Agency



• Medicaments images are for illustrative purposes only and may differ from the actual product.


[*1]

DDD. Information source: WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health


Back


Facebook Tweeter E-mail link
For pharmacies & healthstores For advertisers About

Copyright © 2011-2024 iDrugs24.com. All rights reserved